Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

OptimizeRx (OPRX) Shares Outstanding (2016 - 2025)

OptimizeRx's Shares Outstanding history spans 15 years, with the latest figure at $20.2 million for Q4 2024.

  • For Q4 2024, Shares Outstanding rose 1.48% year-over-year to $20.2 million; the TTM value through Dec 2024 reached $20.2 million, up 1.48%, while the annual FY2024 figure was $20.2 million, 1.48% up from the prior year.
  • Shares Outstanding for Q4 2024 was -$1.7 million at OptimizeRx, roughly flat from -$1.7 million in the prior quarter.
  • Across five years, Shares Outstanding topped out at $19.9 million in Q4 2023 and bottomed at -$1.7 million in Q2 2023.
  • The 5-year median for Shares Outstanding is -$5416.5 (2021), against an average of $5.2 million.
  • The largest annual shift saw Shares Outstanding tumbled 1060.69% in 2022 before it skyrocketed 2703.96% in 2023.
  • A 5-year view of Shares Outstanding shows it stood at $15.2 million in 2020, then rose by 17.33% to $17.9 million in 2021, then grew by 2.39% to $18.3 million in 2022, then rose by 8.81% to $19.9 million in 2023, then increased by 1.48% to $20.2 million in 2024.
  • Per Business Quant, the three most recent readings for OPRX's Shares Outstanding are $20.2 million (Q4 2024), -$1.7 million (Q3 2024), and -$1.7 million (Q2 2024).